|
RAPT
|
RAPT Therapeutics, Inc.
|
4.47%
|
US
|
NASDAQ
|
|
MRUS
|
Merus N.V.
|
4.18%
|
US
|
NASDAQ
|
|
BGNE
|
BeiGene, Ltd.
|
4.13%
|
US
|
NASDAQ
|
|
ACLX
|
Arcellx, Inc.
|
3.81%
|
US
|
NASDAQ
|
|
MRK
|
Merck & Company, Inc.
|
3.66%
|
US
|
NYSE
|
|
JANX
|
Janux Therapeutics, Inc.
|
3.64%
|
US
|
NASDAQ
|
|
AGEN
|
Agenus Inc.
|
3.54%
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
3.52%
|
US
|
NASDAQ
|
|
BCYC
|
Bicycle Therapeutics plc
|
3.52%
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
3.50%
|
US
|
NASDAQ
|
|
GILD
|
Gilead Sciences, Inc.
|
3.50%
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
3.49%
|
US
|
NASDAQ
|
|
LYEL
|
Lyell Immunopharma, Inc.
|
3.48%
|
US
|
NASDAQ
|
|
IMTX
|
Immatics N.V.
|
3.41%
|
US
|
NASDAQ
|
|
ARGX
|
argenx SE
|
3.39%
|
US
|
NASDAQ
|
|
BMY
|
Bristol-Myers Squibb Company
|
3.38%
|
US
|
NYSE
|
|
REPL
|
Replimune Group, Inc.
|
3.37%
|
US
|
NASDAQ
|
|
XNCR
|
Xencor, Inc.
|
3.35%
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
3.32%
|
US
|
NASDAQ
|
|
LEGN
|
Legend Biotech Corporation
|
3.28%
|
US
|
NASDAQ
|